Back
EPAM Systems Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
36
EPAM
EPAM Systems
Last Price:
$159.33
Seasonality Move:
7.33%
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$20.30
Seasonality Move:
8.12%
Sell
36
EPAM Systems (EPAM)
is a Sell
Is EPAM Systems a Buy, Sell or Hold?
-
The current EPAM Systems [EPAM] share price is $160.80. The Score for EPAM is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
EPAM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $20.40. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EPAM Stock Price Chart
What is EPAM Systems's stock price today?
-
The EPAM Systems share price today is $160.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EPAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $20.40Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EPAM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 40.75 | Buy |
Relative Strength Index (14 RSI): | 48.39 | Sell |
Chaikin Money Flow: | 717373 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (155 - 170.24) | Sell |
Bollinger Bands (100): | (155.71 - 179.05) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.95 | Buy |
Relative Strength Index (14 RSI): | 57.41 | Buy |
Chaikin Money Flow: | 8584996 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.15 - 19.17) | Buy |
Bollinger Bands (100): | (17.93 - 55.55) | Sell |
EPAM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 154.4 | Buy |
20-day SMA: | 161 | Sell |
50-day SMA: | 168.88 | Sell |
200-day SMA: | 198.18 | Sell |
8-day EMA: | 148.16 | Buy |
20-day EMA: | 108.96 | Buy |
50-day EMA: | 59.52 | Buy |
200-day EMA: | 17.67 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.93 | Buy |
20-day SMA: | 16.17 | Buy |
50-day SMA: | 21.34 | Sell |
200-day SMA: | 76.43 | Sell |
8-day EMA: | 17.44 | Buy |
20-day EMA: | 12.42 | Buy |
50-day EMA: | 6.68 | Buy |
200-day EMA: | 1.97 | Buy |
EPAM Systems Earnings Growth & EPAM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.77 per share, an increase next quarter of $0.25 per share, an increase this year of $0.18 per share, and an increase next year of $1.11 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.52 per share, an increase next quarter of $1.45 per share, a decrease this year of $5.64 per share, and an increase next year of $5.00 per share.
EPAM Systems Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |